586373-51-5

Basic information

• Product Name: Benzonitrile, 3-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-
• CAS NO: 586373-51-5
• Molecular Formula: C14H21NOSi
• Molecular Weight: 247.412
• Mol File: 586373-51-5.mol
• Article Data: 3

Chemical Properties

• CAS DataBase Reference: Benzonitrile, 3-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-(CAS DataBase Reference)
• NIST Chemistry Reference: Benzonitrile, 3-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-(586373-51-5)
• EPA Substance Registry System: Benzonitrile, 3-[[[(1,1-dimethylethyl)dimethylsilyl]oxy]methyl]-(586373-51-5)

Safety Data

• Hazardous Substances Data: 586373-51-5(Hazardous Substances Data)

Upstream product

• 24964-64-5 3-Cyanobenzaldehyde 
• 874-97-5 3-(hydroxymethyl)benzonitrile 
• 18162-48-6 tert-butyldimethylsilyl chloride 

Downstream Products

• 1003838-62-7 1-(3-((tert-butyldimethylsilyloxy)methyl)phenyl)ethanone 
• 391957-11-2 3-(tert-butyldimethylsilyloxymethyl)benzylamine 

Relevant articles and documents

SELECTIVE ANDROGEN RECEPTOR MODULATORS, ANALOGS AND DERIVATIVES THEREOF AND USES THEREOF

This invention provides new compounds and uses thereof in treating a variety of diseases or conditions in a subject, including,inter alia, prostate cancer, muscle wasting diseases and/or disorders or a bone-related diseases and/or disorders.

SUBSTITUTED PYRIDINONES

Disclosed are compounds of Formula (I) and pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R4, and R5 are defined herein. These compounds are useful for treating diseases and conditions caused or exacerbated by unregulated p38 MAP Kinase and/or TNF activity. Pharmaceutical compositions containing the compounds, methods of preparing the compounds and methods of treatment using the compounds are also disclosed.